AUTOLUS Trademark

Trademark Overview


On Thursday, April 16, 2015, a trademark application was filed for AUTOLUS with the United States Patent and Trademark Office. The USPTO has given the AUTOLUS trademark a serial number of 79168175. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, October 7, 2022. This trademark is owned by Autolus Limited C/O Syncona Partners. The AUTOLUS trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Medical and veterinary preparations, namely, engineered T-cells for therapeutic purposes; preparations for cell therapy, namely, engineered T-cells; preparations for gene therapy, namely, engineered T-cells; biological preparations for cancer therapies; medical preparations, namely, chimeric antigen receptors (CAR) and therapeutic preparations thereof, namely, viral vectors expressing CAR genes; therapeutic antibodies for use as immunotherapeutic agents; preparations for genetically modifying human or animal cells for medical purposes, including viral vectors; preparations of blood extracted from humans or animals which have been adapted for therapeutic purposes

Medical services; veterinary services; medical services in the extraction of human and animal cells from patients; manipulation of human and animal cells for therapeutic purposes; reinsertion of cells into human and animal patients for medical purposes; providing medical and therapy advice and consultancy in the field of medical and veterinary therapies; providing cancer therapy advice and consultancy

Scientific and technological services and research and design relating thereto, namely, scientific research; industrial analysis and research services in the field of T-cells and chimeric antigen receptors; medical and veterinary research services, namely, the manipulation of cells within a laboratory or research facility to enable the cells to be used for therapeutic purposes; scientific research in the development of new cancer therapies; scientific research in human and animal cell therapy; scientific research in human and animal gene therapy; scientific research into vectors and preparations for manipulating and adapting human and animal cells; consultancy relating to all the aforesaid services
autolus

General Information


Serial Number79168175
Word MarkAUTOLUS
Filing DateThursday, April 16, 2015
Status709 - CANCELLED - SECTION 71
Status DateFriday, October 7, 2022
Registration Number4920212
Registration DateTuesday, March 22, 2016
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 5, 2016

Trademark Statements


Goods and ServicesMedical and veterinary preparations, namely, engineered T-cells for therapeutic purposes; preparations for cell therapy, namely, engineered T-cells; preparations for gene therapy, namely, engineered T-cells; biological preparations for cancer therapies; medical preparations, namely, chimeric antigen receptors (CAR) and therapeutic preparations thereof, namely, viral vectors expressing CAR genes; therapeutic antibodies for use as immunotherapeutic agents; preparations for genetically modifying human or animal cells for medical purposes, including viral vectors; preparations of blood extracted from humans or animals which have been adapted for therapeutic purposes
Goods and ServicesMedical services; veterinary services; medical services in the extraction of human and animal cells from patients; manipulation of human and animal cells for therapeutic purposes; reinsertion of cells into human and animal patients for medical purposes; providing medical and therapy advice and consultancy in the field of medical and veterinary therapies; providing cancer therapy advice and consultancy
Goods and ServicesScientific and technological services and research and design relating thereto, namely, scientific research; industrial analysis and research services in the field of T-cells and chimeric antigen receptors; medical and veterinary research services, namely, the manipulation of cells within a laboratory or research facility to enable the cells to be used for therapeutic purposes; scientific research in the development of new cancer therapies; scientific research in human and animal cell therapy; scientific research in human and animal gene therapy; scientific research into vectors and preparations for manipulating and adapting human and animal cells; consultancy relating to all the aforesaid services

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, October 7, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, October 7, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, October 7, 2022
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAutolus Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressGB

Party NameAutolus Limited C/O Syncona Partners
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressGB

Party NameAutolus Limited C/O Syncona Partners
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGB

Trademark Events


Event DateEvent Description
Wednesday, June 7, 2023TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, October 7, 2022CANCELLED SECTION 71
Sunday, October 3, 2021CHANGE OF NAME/ADDRESS REC'D FROM IB
Monday, March 22, 2021COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Friday, July 15, 2016FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, June 23, 2016FINAL DISPOSITION NOTICE SENT TO IB
Thursday, June 23, 2016FINAL DISPOSITION PROCESSED
Wednesday, June 22, 2016FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Friday, April 8, 2016CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
Friday, April 1, 2016CORRECTION TRANSACTION RECEIVED FROM IB
Tuesday, March 22, 2016REGISTERED-PRINCIPAL REGISTER
Tuesday, January 5, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 5, 2016PUBLISHED FOR OPPOSITION
Monday, January 4, 2016NOTIFICATION PROCESSED BY IB
Wednesday, December 16, 2015NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, December 16, 2015NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, December 16, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, November 28, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, November 23, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, November 23, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, November 23, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, August 22, 2015REFUSAL PROCESSED BY IB
Thursday, August 6, 2015NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, August 6, 2015REFUSAL PROCESSED BY MPU
Thursday, August 6, 2015NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, August 5, 2015NON-FINAL ACTION WRITTEN
Monday, July 27, 2015ASSIGNED TO EXAMINER
Friday, July 10, 2015APPLICATION FILING RECEIPT MAILED
Monday, July 6, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, July 2, 2015SN ASSIGNED FOR SECT 66A APPL FROM IB